Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Trump speaking to reporters at the White House in September. Photo: Bill O'Leary/The Washington Post via Getty Images

Pharmaceutical Research and Manufacturers of America (PhRMA) said in a statement Thursday that President Trump's executive order that appears to block federal contractors from holding anti-racist programs or diversity training is "ill-conceived and harmful" and asked that it be rescinded.

Why it matters: PhRMA president and CEO Stephen Ubl warned that the order puts "improper bureaucratic hurdles and restrictions on speech" within private companies that have contracts and grants with the federal government, jeopardizing "meaningful dialogue on the values for which this nation stands."

Context: Trump moved to halt federal agencies' anti-racism training in early September, then expanded the ban to federal contractors. The order suggests these sessions promote "radical ideologies that divide Americans by race or sex."

What they're saying: “The biopharmaceutical industry is doing everything it can to find vaccines and therapeutics to help end a pandemic that has had a disproportionate impact on Black and Brown communities," Ubl wrote in a statement Thursday.

  • “The issue of health inequities is not a new problem. It is a longstanding symptom of the systemic racism experienced by Black and Brown Americans throughout history. It is why our companies have committed to pushing for necessary, positive and long-term change to better address the needs of diverse communities."
  • "And it is why we must speak out against the president’s executive order restricting workplace diversity training programs and free speech within private companies that have contractual partnerships with or grants from the federal government."
  • “Diversity is essential to a robust innovation ecosystem that can create new medicines for those who need them."

The big picture: The Information Technology Industry Council, a tech industry lobbying group, also pushed back against the order last week.

  • CEO Jason Oxman wrote in a statement that it "attacks our broadly shared values and risks undoing real progress toward building racial equity in the tech industry and America writ large."

Go deeper

Trump bans transactions with eight Chinese software apps

Trump speaking at a rally in Dalton, Georgia, on Jan. 4. Photo: Alex Wong/Getty Images

President Trump signed an executive order Tuesday that prohibits transactions with eight Chinese software applications, claiming they pose a national security threat given their ability to access private information about their users.

Why it matters: The order comes two weeks before Trump leaves office, and it remains unclear whether President-elect Biden will continue enforcing Trump’s bans on Chinese companies.

47 mins ago - Sports

Raiders player becomes first active in NFL to come out as gay

Photo: Julio Aguilar via Getty Images

Las Vegas Raiders player Carl Nassib becomes the first active NFL player in history to come out as gay on Monday.

Driving the news: Nassib said he was coming out now because "representation and visibility are so important" and he will be donating $100,000 to the Trevor Project, a suicide prevention service for LGBTQ youth in the U.S.

Airlines, unions want DOJ to prosecute unruly passengers

Photo: Nicolas Economou/NurPhoto via Getty Images

A coalition of airline industry partners asked the Justice Department on Monday to begin prosecuting disruptive passengers.

Why it matters: Increased political divisions and conflict over pandemic guidelines have led the Federal Aviation Administration to take some form of enforcement action over 400 times in the first five months of 2021, compared to 146 in all of 2019, according to the coalition.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!